1. Home
  2. MBI vs PRQR Comparison

MBI vs PRQR Comparison

Compare MBI & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBI
  • PRQR
  • Stock Information
  • Founded
  • MBI 1973
  • PRQR 2012
  • Country
  • MBI United States
  • PRQR Netherlands
  • Employees
  • MBI N/A
  • PRQR N/A
  • Industry
  • MBI Property-Casualty Insurers
  • PRQR Biotechnology: Pharmaceutical Preparations
  • Sector
  • MBI Finance
  • PRQR Health Care
  • Exchange
  • MBI Nasdaq
  • PRQR Nasdaq
  • Market Cap
  • MBI 222.1M
  • PRQR 232.8M
  • IPO Year
  • MBI 1987
  • PRQR 2014
  • Fundamental
  • Price
  • MBI $7.96
  • PRQR $2.25
  • Analyst Decision
  • MBI Buy
  • PRQR Strong Buy
  • Analyst Count
  • MBI 1
  • PRQR 8
  • Target Price
  • MBI $8.00
  • PRQR $8.88
  • AVG Volume (30 Days)
  • MBI 597.6K
  • PRQR 319.5K
  • Earning Date
  • MBI 08-06-2025
  • PRQR 08-07-2025
  • Dividend Yield
  • MBI N/A
  • PRQR N/A
  • EPS Growth
  • MBI N/A
  • PRQR N/A
  • EPS
  • MBI N/A
  • PRQR N/A
  • Revenue
  • MBI $108,000,000.00
  • PRQR $20,129,184.00
  • Revenue This Year
  • MBI N/A
  • PRQR N/A
  • Revenue Next Year
  • MBI N/A
  • PRQR N/A
  • P/E Ratio
  • MBI N/A
  • PRQR N/A
  • Revenue Growth
  • MBI 285.71
  • PRQR 8.65
  • 52 Week Low
  • MBI $3.22
  • PRQR $1.07
  • 52 Week High
  • MBI $8.26
  • PRQR $4.62
  • Technical
  • Relative Strength Index (RSI)
  • MBI 77.41
  • PRQR 57.03
  • Support Level
  • MBI $6.10
  • PRQR $2.18
  • Resistance Level
  • MBI $8.26
  • PRQR $2.33
  • Average True Range (ATR)
  • MBI 0.38
  • PRQR 0.13
  • MACD
  • MBI 0.10
  • PRQR 0.02
  • Stochastic Oscillator
  • MBI 86.73
  • PRQR 84.91

About MBI MBIA Inc.

MBIA Inc provides financial guaranty insurance for municipal bonds and asset-backed securities in the United States and internationally. It offers an unconditional guarantee to repay the principal and interest on these securities if the issuer defaults. MBIA insures bonds sold in the primary and secondary markets, as well as those held in unit investment trusts and mutual funds. It operates in three segments: the United States Public Finance Insurance, which derives maximum revenue, Corporate, and International & Structured Finance Insurance. U.S. public finance insurance portfolio is managed through the National Public Finance Guarantee Corporation. International & structured finance insurance business is managed through MBIA Insurance Corporation and its subsidiary.

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.

Share on Social Networks: